Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Pfizer Limited
Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 06/02/2012
PIL Dynastat 20mg or 40mg Powder and Solvent for Solution for Injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 06/02/2012 and displayed until Current
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to information for healthcare professionals
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to dosage and administration
Updated on 11/07/2011 and displayed until 06/02/2012
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
Updated on 04/03/2011 and displayed until 11/07/2011
Reasons for adding or updating:
  • Change to instructions about overdose
Updated on 17/11/2010 and displayed until 04/03/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 06/09/2010 and displayed until 17/11/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 17/12/2009 and displayed until 06/09/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to name of manufacturer
Updated on 03/04/2009 and displayed until 17/12/2009
Reasons for adding or updating:
  • Change to date of revision
  • Correction of spelling/typing errors
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to Marketing Authorisation Holder
Updated on 18/08/2008 and displayed until 03/04/2009
Reasons for adding or updating:
  • Correction of spelling/typing errors
  • Change of manufacturer
Updated on 25/06/2007 and displayed until 18/08/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 21/05/2007 and displayed until 25/06/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to information about pregnancy or lactation
  • Change to Further Information section
  • Change to date of revision
  • Pending awaiting re-submission
Updated on 21/05/2007 and displayed until 21/05/2007
Reasons for adding or updating:
  • Change of contra-indications
  • Change to warnings or special precautions for use
  • Change to information about pregnancy or lactation
  • Change to Further Information section
  • Change to date of revision
Updated on 09/03/2007 and displayed until 21/05/2007
Reasons for adding or updating:
  • Change to name of manufacturer
  • Change to date of revision
Updated on 20/07/2006 and displayed until 09/03/2007
Reasons for adding or updating:
  • Change to Further Information section
Updated on 28/10/2005 and displayed until 20/07/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to Further Information section
Updated on 16/05/2005 and displayed until 28/10/2005
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
Updated on 10/01/2005 and displayed until 16/05/2005
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 22/12/2004 and displayed until 10/01/2005
Reasons for adding or updating:
  • Change to side-effects
Updated on 11/06/2004 and displayed until 22/12/2004
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  parecoxib sodium